Once-weekly semaglutide use in glucagon-like peptide-1 receptor agonist naïve patients with type 2 diabetes in North Macedonia: Real-world data from the MIRAGE study.

Autor: Milenkovikj T; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, North Macedonia; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, Republic of North Macedonia. Electronic address: milenkovic.tatjana@yahoo.com., Chekorova Mitreva B; Novo Nordisk Farma Dooel, Skopje, North Macedonia., Jovanovska Mishevska S; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, North Macedonia; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, Republic of North Macedonia., Bitoska-Mileva I; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, North Macedonia; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, Republic of North Macedonia., Ahmeti I; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, North Macedonia; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, Republic of North Macedonia.

Publikováno v: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2023 Dec; Vol. 206, pp. 111018. Date of Electronic Publication: 2023 Nov 14.